abs45.txt	transition	metal	complexes	are	of	increasing	interest	as	photosensitizers	inphotodynamic	therapy	(pdt)	and		more	recently	for	photochemotherapy	(pct)	inrecent	years	ru(ii)	polypyridyl	have	emerged	promising	systems	forboth	pdt	pct	their	rich	photochemical	photophysical	properties	derivefrom	a	variety	excited-state	electronic	configurations	accessible	with	visibleand	near-infrared	light	these	can	be	exploited	both	energy-and	electron-transfer	processes	that	yield	highly	potent	oxygen-dependentand/or	oxygen-independent	photobiological	activity	selected	examples	highlightthe	use	rational	design	in	coordination	chemistry	to	control	the	lowest-energytriplet	eliciting	particular	type	ofphotoreactivity	and/or	effects	principles	also	discussedin	context	development	tld1433	first	ru(ii)-basedphotosensitizer	enter	human	clinical	trial	tld1433arose	from	tumor-centered	approach	part	complete	package	thatincludes	component	protocol	treating	non-muscle	invasivebladder	cancer	briefly	this	review	summarizes	challenges	bringing	pdtinto	mainstream	it	considers	chemical	photophysicalsolutions	offer	puts	into	themultidisciplinary	effort	needed	bring	new	drug
